Nomegestrol and chlormadinone containing medicines: Measures to minimise the risk of meningioma

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Active substance
  • nomegestrol
  • chlormadinone
Procedure number
EMEA/H/A-31/1510
Regulatory outcome
Variation
DHPC type
  • Adverse event
  • Referral - Article 31
Referral name
Nomegestrol and chlormadinone
Human ATC code
G03
Dissemination date
08/11/2022

How useful was this page?

Add your rating